Literature DB >> 23632026

Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis.

Oleg V Kovalenko1, Andrea Olland, Nicole Piché-Nicholas, Adarsh Godbole, Daniel King, Kristine Svenson, Valerie Calabro, Mischa R Müller, Caroline J Barelle, William Somers, Davinder S Gill, Lidia Mosyak, Lioudmila Tchistiakova.   

Abstract

The immunoglobulin new antigen receptors (IgNARs) are a class of Ig-like molecules of the shark immune system that exist as heavy chain-only homodimers and bind antigens by their single domain variable regions (V-NARs). Following shark immunization and/or in vitro selection, V-NARs can be generated as soluble, stable, and specific high affinity monomeric binding proteins of ∼12 kDa. We have previously isolated a V-NAR from an immunized spiny dogfish shark, named E06, that binds specifically and with high affinity to human, mouse, and rat serum albumins. Humanization of E06 was carried out by converting over 60% of non-complementarity-determining region residues to those of a human germ line Vκ1 sequence, DPK9. The resulting huE06 molecules have largely retained the specificity and affinity of antigen binding of the parental V-NAR. Crystal structures of the shark E06 and its humanized variant (huE06 v1.1) in complex with human serum albumin (HSA) were determined at 3- and 2.3-Å resolution, respectively. The huE06 v1.1 molecule retained all but one amino acid residues involved in the binding site for HSA. Structural analysis of these V-NARs has revealed an unusual variable domain-antigen interaction. E06 interacts with HSA in an atypical mode that utilizes extensive framework contacts in addition to complementarity-determining regions that has not been seen previously in V-NARs. On the basis of the structure, the roles of various elements of the molecule are described with respect to antigen binding and V-NAR stability. This information broadens the general understanding of antigen recognition and provides a framework for further design and humanization of shark IgNARs.

Entities:  

Keywords:  Albumin; Antibodies; Antibody Engineering; Antigen; Crystal Structure; Humanization; IgNAR; V-NAR

Mesh:

Substances:

Year:  2013        PMID: 23632026      PMCID: PMC3682541          DOI: 10.1074/jbc.M112.435289

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.

Authors:  Aline Desmyter; Silvia Spinelli; Francoise Payan; Marc Lauwereys; Lode Wyns; Serge Muyldermans; Christian Cambillau
Journal:  J Biol Chem       Date:  2002-04-17       Impact factor: 5.157

2.  Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.

Authors:  Akiko Koide; Stacy Abbatiello; Lisa Rothgery; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.

Authors:  M Lauwereys; M Arbabi Ghahroudi; A Desmyter; J Kinne; W Hölzer; E De Genst; L Wyns; S Muyldermans
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

4.  Dimerisation strategies for shark IgNAR single domain antibody fragments.

Authors:  David P Simmons; Fiona A Abregu; Usha V Krishnan; David F Proll; Victor A Streltsov; Larissa Doughty; Meghan K Hattarki; Stewart D Nuttall
Journal:  J Immunol Methods       Date:  2006-08-28       Impact factor: 2.303

5.  Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.

Authors:  Katja Conrath; Cécile Vincke; Benoît Stijlemans; Joost Schymkowitz; Klaas Decanniere; Lode Wyns; Serge Muyldermans; Remy Loris
Journal:  J Mol Biol       Date:  2005-07-01       Impact factor: 5.469

6.  Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.

Authors:  Kylie A Henderson; Victor A Streltsov; Andrew M Coley; Olan Dolezal; Peter J Hudson; Adrian H Batchelor; Aditi Gupta; Tao Bai; Vincent J Murphy; Robin F Anders; Michael Foley; Stewart D Nuttall
Journal:  Structure       Date:  2007-11       Impact factor: 5.006

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 8.  Shark novel antigen receptors--the next generation of biologic therapeutics?

Authors:  Caroline Barelle; Davinder S Gill; Keith Charlton
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 9.  Molecular engineering and design of therapeutic antibodies.

Authors:  Leonard G Presta
Journal:  Curr Opin Immunol       Date:  2008-08       Impact factor: 7.486

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  28 in total

1.  The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope.

Authors:  Stefan Zielonka; Martin Empting; Doreen Könning; Julius Grzeschik; Simon Krah; Stefan Becker; Stephan Dickgießer; Harald Kolmar
Journal:  Mar Biotechnol (NY)       Date:  2015-05-24       Impact factor: 3.619

Review 2.  Structural and genetic diversity in antibody repertoires from diverse species.

Authors:  Miguel de los Rios; Michael F Criscitiello; Vaughn V Smider
Journal:  Curr Opin Struct Biol       Date:  2015-07-17       Impact factor: 6.809

Review 3.  The immunoglobulins of cartilaginous fishes.

Authors:  Hanover Matz; Danish Munir; James Logue; Helen Dooley
Journal:  Dev Comp Immunol       Date:  2020-09-23       Impact factor: 3.636

4.  Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.

Authors:  Samata S Pandey; Marina Kovaleva; Caroline J Barelle; Obinna C Ubah
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Engineered Autonomous Human Variable Domains.

Authors:  Johan Nilvebrant; Peter M Tessier; Sachdev S Sidhu
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 6.  Ancient species offers contemporary therapeutics: an update on shark VNAR single domain antibody sequences, phage libraries and potential clinical applications.

Authors:  Hejiao English; Jessica Hong; Mitchell Ho
Journal:  Antib Ther       Date:  2020-01-21

7.  VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry.

Authors:  Julien Häsler; Martin F Flajnik; Gareth Williams; Frank S Walsh; J Lynn Rutkowski
Journal:  Mol Immunol       Date:  2016-05-20       Impact factor: 4.407

8.  Structural insights and biomedical potential of IgNAR scaffolds from sharks.

Authors:  Stefan Zielonka; Martin Empting; Julius Grzeschik; Doreen Könning; Caroline J Barelle; Harald Kolmar
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 9.  An update on antibody-based immunotherapies for Clostridium difficile infection.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Clin Exp Gastroenterol       Date:  2016-08-01

Review 10.  Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications.

Authors:  Salma Nassor Juma; Xiaoxia Gong; Sujie Hu; Zhengbing Lv; Jianzhong Shao; Lili Liu; Guiqian Chen
Journal:  Cells       Date:  2021-05-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.